Developer docs
API playgroundTry for free, no card

Search company profiles

Iodine Software

Full company profile

uuid0002pzn

Namestring
Iodine Software
Legal namestring
Iodine Software
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Iodine Software is a healthcare AI company that provides clinical AI solutions for revenue cycle management, serving over 800 hospitals and 80,000 healthcare providers across the United States. The company's core offering is a Clinical AI Engine that combines predictive analytics, natural language processing, anomaly detection, and process automation to enhance clinical documentation, physician engagement, and reimbursement optimization. The platform was extended through two 2021 acquisitions: Artifact Health (a mobile-based physician query platform acquired in May 2021) and ChartWise Medical Systems (a CDI software provider acquired in June 2021), which broadened Iodine's reach into physician-facing documentation tools and adjacent clinical documentation workflows. The company operates on a subscription-based enterprise software model, selling its clinical AI solutions directly to large hospital systems and health systems through an enterprise field sales motion. Following a growth investment from Advent International in December 2021 that valued the company at over $1 billion, Iodine Software was acquired by Waystar Holding Corp. (NASDAQ:WAY) in October 2025 for $1.25 billion. Iodine's clinical AI capabilities are now integrated into Waystar's AltitudeAI platform, combining clinical and financial datasets to serve over 1,000 hospitals and health systems.

Short descriptiontext

Iodine Software is a healthcare AI company providing clinical AI solutions for revenue cycle management, serving 800+ hospitals and 80,000+ providers. Acquired by Waystar (NASDAQ:WAY) in October 2025 for $1.25 billion.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical AI software, revenue cycle management, clinical documentation integrity, healthcare AI, physician query platform
NAICS code2 codes
  • Software Publishers5132
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare Revenue Cycle Management Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical AI Solutions
TypeSubscription Recurring
Description

Iodine Software provides clinical AI solutions to healthcare providers, generating revenue through subscription-based software solutions used by hospitals and health systems for clinical intelligence and revenue cycle optimization.

finsmes.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Iodine Software provides AI-powered clinical intelligence software for hospitals and health systems, combining a clinical predictions engine, a mobile-based physician query platform, and clinical documentation integrity tools to improve documentation accuracy, streamline physician workflows, and optimize reimbursement and revenue cycle outcomes. The offerings are sold as subscription-based enterprise software to US healthcare providers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 800+ hospitals and 80,000+ providers served
+1 more record
Product overview1 text field

Iodine Software is a healthcare AI company (acquired by Waystar in 2025 for $1.25 billion) that provides clinical AI solutions for revenue cycle management. The company's offerings include a Clinical AI Engine for predictive analytics and clinical decision support, enhanced through the 2021 acquisition of Artifact Health's mobile physician query platform. These solutions are now integrated into Waystar's AltitudeAI platform, combining clinical predictions with financial data to serve over 1,000 hospitals and health systems.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-05-25
Description

Iodine Software acquired Artifact Health to enhance its clinical predictions and physician engagement capabilities. The acquisition added mobile-based query functionalities and expanded Iodine's healthcare AI offerings.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major EHR and RCM platform provider embedding clinical AI into its hospital systems post-Cerner acquisition. Comparable as a large incumbent building an integrated clinical+financial AI suite that overlaps with Iodine's positioning.

TypeEmerging player
Description

Healthcare AI company automating revenue cycle and operational workflows for hospitals. Comparable as an early AI-native RCM peer, though it has faced significant business-model and execution headwinds.

TypeDirect peer
Description

Long-standing market leader in computer-assisted coding and clinical documentation integrity for hospitals. Highly comparable because 3M's CDI and CAC products compete head-to-head with Iodine's Clinical Documentation Integrity module for the same hospital HIM budgets.

TypeDirect peer
Description

Provider of end-to-end revenue cycle management technology and services to hospitals and physician groups. Comparable as a direct competitor in hospital RCM with overlapping modules around denials, coding, and CDI that increasingly use AI/automation.

TypeBroad incumbent
Description

Spin-out of 3M's Health Care segment including Health Information Systems. Comparable as a broad incumbent in hospital coding, CDI, and RCM technology competing for the same hospital budgets as Iodine.

TypeBroad incumbent
Description

Provider of clinical documentation and ambient AI (DAX Copilot) for physicians, now part of Microsoft. Comparable through its overlap with Iodine's clinical-documentation and physician-engagement use cases via the Artifact Health-style query workflow.

TypeBroad incumbent
Description

Dominant EHR vendor increasingly embedding AI-driven documentation, coding, and revenue cycle capabilities directly into its platform. Comparable as a competitive threat: Epic's native AI roadmap could disintermediate standalone CDI vendors like Iodine over time.

TypeEmerging player
Description

AI-native healthcare revenue cycle automation company targeting hospitals and health systems. Comparable as an emerging competitor building AI-driven RCM workflows, though focused more on autonomous operations and patient access than CDI specifically.

TypeDirect peer
Description

Parent company following October 2025 acquisition. Waystar provides healthcare RCM software and is the direct platform Iodine's clinical AI is now integrated into via AltitudeAI. It is the most comparable company because it now owns and operates Iodine's products alongside its own claims, payment, and denial management suite.

TypeBroad incumbent
Description

Optum's RCM and analytics offerings (including Optum360 coding, CDI, and AI services) compete with Iodine across the hospital revenue cycle. Comparable as a large incumbent leveraging payer data and scale to deliver clinical-AI-augmented RCM.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights1 record

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Iodine Software

Healthcare Revenue Cycle Management Softwareiodinesoftware.com

Iodine Software is a healthcare AI company providing clinical AI solutions for revenue cycle management, serving 800+ hospitals and 80,000+ providers. Acquired by Waystar (NASDAQ:WAY) in October 2025 for $1.25 billion.

What Iodine Software does

Iodine Software is a healthcare AI company that provides clinical AI solutions for revenue cycle management, serving over 800 hospitals and 80,000 healthcare providers across the United States. The company's core offering is a Clinical AI Engine that combines predictive analytics, natural language processing, anomaly detection, and process automation to enhance clinical documentation, physician engagement, and reimbursement optimization. The platform was extended through two 2021 acquisitions: Artifact Health (a mobile-based physician query platform acquired in May 2021) and ChartWise Medical Systems (a CDI software provider acquired in June 2021), which broadened Iodine's reach into physician-facing documentation tools and adjacent clinical documentation workflows. The company operates on a subscription-based enterprise software model, selling its clinical AI solutions directly to large hospital systems and health systems through an enterprise field sales motion. Following a growth investment from Advent International in December 2021 that valued the company at over $1 billion, Iodine Software was acquired by Waystar Holding Corp. (NASDAQ:WAY) in October 2025 for $1.25 billion. Iodine's clinical AI capabilities are now integrated into Waystar's AltitudeAI platform, combining clinical and financial datasets to serve over 1,000 hospitals and health systems.

Iodine Software firmographics

Firmographics
Name
Iodine Software
Legal name
Iodine Software
Website
https://iodinesoftware.com
Company type
Private
Founded year
2010
Operating status
Acquired
Headcount range
251–500 employees
Short description
Iodine Software is a healthcare AI company providing clinical AI solutions for revenue cycle management, serving 800+ hospitals and 80,000+ providers. Acquired by Waystar (NASDAQ:WAY) in October 2025 for $1.25 billion.
Ownership category
akta.pro rank

Where Iodine Software is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Iodine Software business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Clinical AI Solutions: Iodine Software provides clinical AI solutions to healthcare providers, generating revenue through subscription-based software solutions used by hospitals and health systems for clinical intelligence and revenue cycle optimization.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Iodine Software product offering

Product offering

Core offering

Iodine Software provides AI-powered clinical intelligence software for hospitals and health systems, combining a clinical predictions engine, a mobile-based physician query platform, and clinical documentation integrity tools to improve documentation accuracy, streamline physician workflows, and optimize reimbursement and revenue cycle outcomes. The offerings are sold as subscription-based enterprise software to US healthcare providers.

Product overview

Iodine Software is a healthcare AI company (acquired by Waystar in 2025 for $1.25 billion) that provides clinical AI solutions for revenue cycle management. The company's offerings include a Clinical AI Engine for predictive analytics and clinical decision support, enhanced through the 2021 acquisition of Artifact Health's mobile physician query platform. These solutions are now integrated into Waystar's AltitudeAI platform, combining clinical predictions with financial data to serve over 1,000 hospitals and health systems.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 800+ hospitals and 80,000+ providers served
  • +1 more outcomes

Companies that use Iodine Software

Customer profile

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Iodine Software technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature3 records

Iodine Software partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Artifact HealthminorStrategic or Co-development Partner · 25 May 2021Iodine Software acquired Artifact Health to enhance its clinical predictions and physician engagement capabilities. The acquisition added mobile-based query functionalities and expanded Iodine's healthcare AI offerings.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Iodine Software competitors and assessment

Company assessment

Broad incumbents

  • Oracle Health (Cerner): Major EHR and RCM platform provider embedding clinical AI into its hospital systems post-Cerner acquisition. Comparable as a large incumbent building an integrated clinical+financial AI suite that overlaps with Iodine's positioning.
  • Solventum (formerly 3M Health Care): Spin-out of 3M's Health Care segment including Health Information Systems. Comparable as a broad incumbent in hospital coding, CDI, and RCM technology competing for the same hospital budgets as Iodine.
  • Nuance (Microsoft): Provider of clinical documentation and ambient AI (DAX Copilot) for physicians, now part of Microsoft. Comparable through its overlap with Iodine's clinical-documentation and physician-engagement use cases via the Artifact Health-style query workflow.
  • Epic Systems: Dominant EHR vendor increasingly embedding AI-driven documentation, coding, and revenue cycle capabilities directly into its platform. Comparable as a competitive threat: Epic's native AI roadmap could disintermediate standalone CDI vendors like Iodine over time.
  • Optum (UnitedHealth Group): Optum's RCM and analytics offerings (including Optum360 coding, CDI, and AI services) compete with Iodine across the hospital revenue cycle. Comparable as a large incumbent leveraging payer data and scale to deliver clinical-AI-augmented RCM.

Emerging players

  • Olive AI: Healthcare AI company automating revenue cycle and operational workflows for hospitals. Comparable as an early AI-native RCM peer, though it has faced significant business-model and execution headwinds.
  • AKASA: AI-native healthcare revenue cycle automation company targeting hospitals and health systems. Comparable as an emerging competitor building AI-driven RCM workflows, though focused more on autonomous operations and patient access than CDI specifically.

Direct peers

  • 3M Health Information Systems: Long-standing market leader in computer-assisted coding and clinical documentation integrity for hospitals. Highly comparable because 3M's CDI and CAC products compete head-to-head with Iodine's Clinical Documentation Integrity module for the same hospital HIM budgets.
  • R1 RCM: Provider of end-to-end revenue cycle management technology and services to hospitals and physician groups. Comparable as a direct competitor in hospital RCM with overlapping modules around denials, coding, and CDI that increasingly use AI/automation.
  • Waystar Holding Corp. Parent company following October 2025 acquisition. Waystar provides healthcare RCM software and is the direct platform Iodine's clinical AI is now integrated into via AltitudeAI. It is the most comparable company because it now owns and operates Iodine's products alongside its own claims, payment, and denial management suite.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights1 record

Customer concentration

Iodine Software social profiles

Digital presence

Iodine Software financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Iodine Software leadership team

Management profile

Number of profiles

Profiles8 records

Iodine Software subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Iodine Software funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Iodine Software M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Iodine Software

What does Iodine Software do?

Iodine Software provides AI-powered clinical intelligence software for hospitals and health systems, combining a clinical predictions engine, a mobile-based physician query platform, and clinical documentation integrity tools to improve documentation accuracy, streamline physician workflows, and optimize reimbursement and revenue cycle outcomes. The offerings are sold as subscription-based enterprise software to US healthcare providers.

Is Iodine Software a public or private company?

Iodine Software is a private company. It is classified as corporate owned and is currently acquired.

When was Iodine Software founded?

Iodine Software was founded in 2010. It employs 251 to 500 people.

Where is Iodine Software based?

Iodine Software is headquartered in Austin, United States, in the North America region.

How does Iodine Software make money?

One revenue line is on record: clinical AI Solutions.

Who are Iodine Software's main competitors?

Broad incumbents on record are Oracle Health (Cerner), Solventum (formerly 3M Health Care), Nuance (Microsoft), Epic Systems and Optum (UnitedHealth Group). Emerging players are Olive AI and AKASA. Direct peers are 3M Health Information Systems, R1 RCM and Waystar Holding Corp..

Does Iodine Software have an API?

No public API is recorded for Iodine Software.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
New Market PitchHealthcare AI M&A: what is happening now?A comprehensive market analysis of healthcare AI M&A activity identified 30 relevant deals between June 2024 and June 2026, with deal count accelerating from 9 in the earlier 12-month period to 21 in the most recent one—roughly 2.3 times more active. The disclosed and semi-disclosed value pool exceeds $17 billion across 12 deals, with the largest being Qualtrics' $6.75 billion acquisition of Press Ganey Forsta, followed by GE HealthCare's $2.3 billion purchase of Intelerad and Waystar's $1.25 billion acquisition of Iodine Software. The analysis shows healthcare AI M&A is shifting from scattered experimentation toward platform consolidation, with strategic buyers focused on acquiring workflow control, proprietary healthcare data, distribution, and the ability to embed AI into processes where revenue or clinical work moves.FortunebusinessinsightsDenials Management Software Market Size, Share [2034]The global denials management software market was valued at USD 1.32 billion in 2025 and is projected to reach USD 4.46 billion by 2034, growing at a CAGR of 14.69%, driven by rising claim denial rates and increasing administrative burden on healthcare providers. The market is consolidating as key players such as Waystar, Experian Information Solutions, Iodine Software, and Finvi invest in AI-powered product launches and strategic partnerships to capture market share. North America led the market in 2025 with USD 0.81 billion in revenue, while Asia Pacific is positioned as the third-largest region with estimated revenues of USD 0.22 billion in 2026.GlobeNewswireGlobal AI in Hospital Operations Market Set to Surge to USD 25.70 Billion by 2030 | MarketsandMarkets™The global AI in hospital operations market is projected to grow from USD 7.51 billion in 2025 to USD 25.70 billion by 2030, representing a 27.9% CAGR, driven by healthcare workforce shortages, escalating administrative complexity, and the need for operational efficiency improvements. Key applications include revenue cycle automation, patient flow management, and staffing optimization, with the Asia Pacific region experiencing the fastest growth. The competitive landscape includes major technology and healthcare IT players such as IBM, Microsoft, Siemens Healthineers, and Philips, alongside recent strategic developments including Waystar's acquisition of Iodine Software, GE HealthCare partnerships with health systems, and Tampa General Hospital's deployment of AI voice agents.HIT ConsultantCB Insights Report: Digital Health Funding Hits $22.3B as 14 New Unicorns EmergeCB Insights' report states that digital health funding increased by 19% year-over-year to $22.3 billion in 2025, with significant growth in M&A activity and the emergence of 14 new unicorns focused on AI. Major acquisitions include Thermo Fisher’s $9.4 billion purchase of Clario and Waystar’s $1.3 billion acquisition of Iodine Software, emphasizing the strategic importance of AI data and proprietary datasets.Built InTop Natural Language Processing Companies 2025The article presents a list of top Natural Language Processing companies for 2025, featuring profiles of organizations such as Iodine Software, Kensho Technologies, Kustomer, and Pfizer. It highlights their specific applications in sectors including healthcare, fintech, defense, and productivity software. The content serves as a directory of industry players utilizing AI and machine learning technologies.HydeparkcapitalDigital Health Market Insights - Fall 2025Global digital health equity funding declined by 13.5% to $4.5 billion in Q3 2025, though the average deal size increased and M&A activity rose with notable transactions like Waystar's acquisition of Iodine Software. The behavioral health technology sector is expanding rapidly, projected to reach $77.6 billion by 2030, driven by rising demand for virtual care and significant U.S. government investments in mental health infrastructure.PR NewswireWaystar Reports Third Quarter 2025 ResultsWaystar Holding Corp. reported third quarter 2025 results with revenue of $268.7 million, up 12% year-over-year, and net income of $30.6 million, while non-GAAP net income reached $67.8 million with an adjusted EBITDA margin of 42%. The company raised its full-year 2025 guidance, expecting total revenue between $1.085 billion and $1.093 billion and adjusted EBITDA between $451 million and $455 million. CEO Matt Hawkins highlighted continued strong demand and the ongoing integration of Iodine Software to enhance Waystar's AI-powered healthcare payment platform.Texas CEO MagazineTexas Weekly Deal HighlightsThe article reports on various business deals and company activities in Texas, particularly in Austin, including a $1.25 billion acquisition of Iodine Software by Waystar and several startup funding rounds.openPR.comUnited States Healthcare Automation Tools Market 2025 | Industry Developments, Future Growth, Share & Industry InsightsThe healthcare automation tools market was valued at US$ 47.91 billion in 2024 and is projected to reach US$ 116.83 billion by 2033, a CAGR of 10.5%. Recent deals include Waystar's $1.25B acquisition of Iodine Software and Siemens' $5.1B purchase of Dotmatics.openPR.comUnited States Healthcare Automation Tools Market 2025 | Growth Drivers, Market Forecast, Competitive Landscape & Business OpportunitiesThe healthcare automation tools market was valued at US$47.91 billion in 2024 and is projected to reach US$116.83 billion by 2033, a CAGR of 10.5%. Recent developments include Midi Health's $50 million Series C funding and Waystar's acquisition of Iodine Software.